Background RDW is critical to the clinical diagnosis and progression of ESRD. There is currently little data on the relationship between RDW and ESRD in sub-Saharan Africa. Because of this, the present study evaluates RDW in patients with ESRD and associated factors in Addis Ababa, Ethiopia. Methods The hospital-based cross-sectional study design was conducted on a total of 83 patients. RDW, MCV, SCR, BUN, GFR, FBS and serum albumin were determined. Blood pressure (mmHg), weight (kg), height (m), MUAC (cm) and BMI (kg/m2) were also measured. Data entry was via Epi-data version 3.4 and analyzed with SPSS version 26.0. A multivariate logistic regression analysis with a p-value < 0.05 at a 95% confidence interval was used to identify the associated factors of RDW. Results A total of 83 ESRD patients participated, with a response rate of 95.4%. RDW ranged from 15.5% to 23.6% with a mean of 17.40% + 1.46%. Anisocytosis was present in 98.8% of patients. Of 83 patients, 66.3% were hypertensive, 20.5% had diabetes, and the remaining 13.3% had other conditions (glomerulonephritis and peripheral vascular disease). The mean GFR value was 5.20 mL/min/1.73 + 1.58. RDW showed a significant association with GFR (AOR: 4.6, 95% CI [1.27, 20.74], P = 0.047), alcohol consumption (AOR: 13.4, P = 0.012, 95% CI [1.97, 22.62]), recurrent kidney disease (AOR=25.6, P=0.016, 95% CI [1.85, 53.71]) and use of medication (AOR=00.2, P=0.044), 95% CI [0.03, 0.95]). Conclusion RDW showed a significant association with GFR, recurrent kidney disease, alcohol consumption, and medication use in hemodialysis-dependent ESRD patients. The mechanisms of RDW disruption in ESRD patients need further investigation.
Background: Treatment outcome results serve as a proxy of the quality of TB treatment for children In Ethiopia, data on TB treatment outcomes in children are limited. The aim of this study was, therefore, to determine the magnitude of tuberculosis treatment outcome in children and associated factors in health facilities of Shashemene, Southern Ethiopia Methods: A cross-sectional study design was conducted from February 10 to March 10, 2019 at Shashemene town, Southern Ethiopia. Using a simple random sampling method, 390 registered TB patients who had known treatment outcomes were selected from Unit TB register logbook. The data entered to Epi Info version 7, and analyzed using SPSS version 23 the characteristic and the treatment outcomes of patients’ were summarized using descriptive statistics. Significant variables at p-value < 0.25 in the bivariate analysis were entered to multivariable logistic regression. Multivariable logistic regression model was used to find factors associated with tuberculosis treatment outcomes in children.Results: Out of 390 children, 201(51. 5%) were females, 138(35.4%) were under 5 years old, and 373(95. 6%) of them were new cases. Pulmonary smear-negative TB accounted for more than half 213(54.6%), EPTB accounted for 140(35.9%) and pulmonary smear-positive TB accounted for 37(9.5%). The overall treatment success rate was 356(91.3%). Among 390 patients, 25(6.4%) were cured, 331(84.9%) were treatment completed, 14(3.6%) were lost to follow up, 17(4.4%) were deaths, and 3(0.7%) were treatment failures. Age group 5-9 years (AOR = 0.362, 95% CI [0.138-0.950]), 10-14 years (AOR =0.354, 95% CI [0.130-0.963]), lost to follow up category of TB (AOR=8.166, 95% CI [1.437-46.410]), HIV positive sero-status (AOR =5.822, 95% CI [2.009-16.869]), and rural residence (AOR= 2.390, 95% CI [1.002-5.702] were independently associated with treatment outcomes. Conclusions: he treatment success rate was above End TB Strategy. The treatment outcome was considerably varied with age, HIV status and residence of the patient. Young children less than 5 years, HIV co-infected and those patients with rural residence needs follow up to reduce poor treatment outcomes among children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.